A great number of studies performed also in patients [41] have shown that HMG-CoA-reductase inhibitors limit the progression of atherosclerosis and may even induce its regression and that glitazones are anti-inflammatory and anti-atherogenic agents besides anti-diabetic [42]. The gene discussed is HMGCR; the disease is atherosclerosis.